HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sulfonylurea-induced hypoglycaemia: use of octreotide.

Abstract
Sulfonylurea compounds are commonly used to treat type 2 diabetes mellitus. The case of an old alcoholic addicted diabetic patient treated with gliquidone developing recurrent and prolonged hypoglycaemias refractory to dextrose administration is related. According to the emergency literature, the use of octreotide in sulfonyurea-induced hypoglycaemia refractory to dextrose administration is related to overdoses of SUA. Use of octreotide with our patient allowed stabilization of the glycaemia.
AuthorsB Hanchard, C Boulouffe, D Vanpee
JournalActa clinica Belgica (Acta Clin Belg) 2009 Jan-Feb Vol. 64 Issue 1 Pg. 56-8 ISSN: 1784-3286 [Print] England
PMID19317242 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Gastrointestinal Agents
  • Sulfonylurea Compounds
  • Octreotide
Topics
  • Aged, 80 and over
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Hypoglycemia (chemically induced, drug therapy)
  • Male
  • Octreotide (therapeutic use)
  • Sulfonylurea Compounds (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: